Iván Alejandro
Ferraz Amaro
Publications by the researcher in collaboration with Iván Alejandro Ferraz Amaro (17)
2023
-
Disease activity in patients with rheumatoid arthritis increases serum levels of apolipoprotein C-III
Clinical and experimental rheumatology, Vol. 41, Núm. 1, pp. 67-73
-
Serum Levels of Lipoprotein Lipase Are Increased in Patients with Inflammatory Bowel Disease
International journal of molecular sciences, Vol. 24, Núm. 6
2022
-
Amylin serum levels are upregulated in patients with systemic lupus erythematosus
Clinical and Experimental Rheumatology, Vol. 40, Núm. 7, pp. 1378-1384
-
Apolipoprotein C-III is linked to the insulin resistance and beta-cell dysfunction that are present in rheumatoid arthritis
Arthritis Research and Therapy, Vol. 24, Núm. 1
-
Apolipoprotein C3 Is Downregulated in Patients With Inflammatory Bowel Disease
Clinical and translational gastroenterology, Vol. 13, Núm. 6, pp. e00500
-
Key Molecules of Triglycerides Pathway Metabolism Are Disturbed in Patients With Systemic Lupus Erythematosus
Frontiers in Immunology, Vol. 13
-
The angiopoietin-like protein 4, apolipoprotein C3, and lipoprotein lipase axis is disrupted in patients with rheumatoid arthritis
Arthritis Research and Therapy, Vol. 24, Núm. 1
2021
-
Differences in Capacity of High-Density Lipoprotein Cholesterol Efflux Between Patients With Systemic Lupus Erythematosus and Rheumatoid Arthritis
Arthritis Care and Research, Vol. 73, Núm. 11, pp. 1590-1596
-
HDL cholesterol efflux capacity and lipid profile in patients with systemic sclerosis
Arthritis Research and Therapy, Vol. 23, Núm. 1
-
Higher prevalence and degree of insulin resistance in patients with rheumatoid arthritis than in patients with systemic lupus erythematosus
Journal of Rheumatology, Vol. 48, Núm. 3
-
Proprotein convertase subtilisin/kexin type 9 in the dyslipidaemia of patients with axial spondyloarthritis is related to disease activity
Rheumatology (Oxford, England), Vol. 60, Núm. 5, pp. 2296-2306
2020
-
Comparable effects of traditional cardiovascular risk factors on subclinical atherosclerosis in systemic lupus erythematosus and rheumatoid arthritis
Clinical and Experimental Rheumatology, Vol. 38, Núm. 5, pp. 917-924
-
Impaired HDL cholesterol efflux capacity in systemic lupus erythematosus patients is related to subclinical carotid atherosclerosis
Rheumatology (Oxford, England), Vol. 59, Núm. 10, pp. 2847-2856
-
Insulin resistance in non-diabetes patients with spondyloarthritis
Scandinavian Journal of Rheumatology, pp. 1-8
-
Proprotein convertase subtilisin/kexin type 9 in patients with systemic sclerosis
Clinical and Experimental Rheumatology, Vol. 38, pp. S18-S24
-
Proprotein convertase subtilisin/kexin type 9 is related to disease activity and damage in patients with systemic erythematosus lupus
Therapeutic Advances in Musculoskeletal Disease, Vol. 12
-
The number of traditional cardiovascular risk factors is independently correlated with disease activity in patients with psoriatic arthritis
Medicina (Lithuania), Vol. 56, Núm. 8, pp. 1-9